Evidence map›Paper›PMID 25857817›Full record

ArticleThe British journal of dermatology2015

Mutational status of naevus-associated melanomas.

D Shitara, G Tell-Martí, C Badenas, M M S S Enokihara, L Alós, A B Larque, N Michalany, J A Puig-Butille, C Carrera, J Malvehy and 2 more

Abstract readMulticenter Study
In one paragraph

Article in The British journal of dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Nevi and Melanoma.Hematology/oncology clinics of North America · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Novel insights into the pathogenesis and treatment of NRAS mutant melanoma.Expert review of precision medicine and drug development · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Melanoma management · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

D ShitaraDepartment of Dermatology, Federal University of São Paulo, São Paulo, Brazil.
G Tell-MartíMelanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
C BadenasMelanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
M M S S EnokiharaDepartment of Dermatology, Federal University of São Paulo, São Paulo, Brazil.
L AlósMelanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
A B LarqueMelanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
N MichalanyDepartment of Dermatology, Federal University of São Paulo, São Paulo, Brazil.
J A Puig-ButilleMelanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
C CarreraMelanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
J MalvehyMelanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
S PuigMelanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.
E BagatinDepartment of Dermatology, Federal University of São Paulo, São Paulo, Brazil.

Funding

Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
NCI NIH HHS CA83115NCI NIH HHS R01 CA083115
6 · The paper itself

Abstract

backgroundThe origin of melanoma has always been a debated subject, as well as the role of adjacent melanocytic naevi. Epidemiological and histopathological studies point to melanomas arising either de novo or from a naevus.

objectivesTo evaluate the presence of mutations in genes from well-known melanomagenesis pathways in a large series of naevus-associated melanomas. MATERIALS AND

methodsSixty-one melanomas found in association with a pre-existing naevus were microdissected, after careful selection of cell subpopulations, and submitted to Sanger sequencing of the BRAF, NRAS, c-KIT, PPP6C, STK19 and RAC1 genes. Each gene was evaluated twice in all samples by sequencing or by sequencing and another confirmation method, allele-specific fluorescent polymerase chain reaction (PCR) and capillary electrophoresis detection or by SNaPshot analysis. Only mutations confirmed via two different molecular methods or twice by sequencing were considered positive.

resultsThe majority of cases presented concordance of mutational status between melanoma and the associated naevus for all six genes (40 of 60; 66.7%). Nine cases presented concomitant BRAF and NRAS mutations, including one case in which both the melanoma and the adjacent naevus harboured V600E and Q61K double mutations. In two cases, both melanoma and associated naevus located on acral sites were BRAF mutated, including an acral lentiginous melanoma.

conclusionsTo our knowledge this is the largest naevus-associated melanoma series evaluated molecularly. The majority of melanomas and adjacent naevi in our sample share the same mutational profile, corroborating the theory that the adjacent naevus and melanoma are clonally related and that the melanoma originated within a naevus.

Indexed as

Genes, NeoplasmGTP PhosphohydrolasesHumansMelanomaMembrane ProteinsMolecular Sequence DataMutationNevus, PigmentedNuclear ProteinsPhosphoprotein PhosphatasesPolymerase Chain ReactionProtein Serine-Threonine KinasesProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-kitrac1 GTP-Binding ProteinSkin NeoplasmsGTP PhosphohydrolasesMembrane ProteinsNRAS protein, humanNuclear ProteinsPhosphoprotein Phosphatasesprotein phosphatase 6Protein Serine-Threonine KinasesProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-kitrac1 GTP-Binding ProteinSTK19 protein, human

Identifiers

PMID25857817
PMCPMC4583836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.